Azathioprine Sodium and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Azathioprine Sodium and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: azathioprine
Brand name: Azasan, Imuran
Synonyms: Azathioprine, AzaTHIOprine
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Azathioprine Sodium-Insulin degludec
- Azathioprine Sodium-Insulin Degludec (U-100) Prefilled Pens
- Azathioprine Sodium-Insulin Degludec (U-100) Vials
- Azathioprine Sodium-Insulin Degludec (U-200) Prefilled Pens
- Azathioprine Sodium-Insulin degludec and liraglutide
- Azathioprine Sodium-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Azathioprine Tablets
- Insulin aspart, recombinant Subcutaneous-Azedra
- Insulin aspart, recombinant Subcutaneous-Azedra Dosimetric
- Insulin aspart, recombinant Subcutaneous-Azedra Injection
- Insulin aspart, recombinant Subcutaneous-Azedra Therapeutic
- Insulin aspart, recombinant Subcutaneous-Azelaic Acid